• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基质辅助激光解吸电离成像质谱揭示肝内胆管癌的肿瘤异质性

Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.

作者信息

Le Faouder Julie, Laouirem Samira, Alexandrov Theodore, Ben-Harzallah Soundes, Léger Thibaut, Albuquerque Miguel, Bedossa Pierre, Paradis Valérie

机构信息

Claude Bernard Institute, Paris-Diderot University, Paris, France; INSERM U773, Biomedical Research Center, Paris-Diderot University, Paris, France.

出版信息

Proteomics. 2014 Apr;14(7-8):965-72. doi: 10.1002/pmic.201300463.

DOI:10.1002/pmic.201300463
PMID:24678008
Abstract

Cholangiocarcinoma (CC) is the second most common primary malignancy of the liver. Although all CC derive from biliary epithelial cells, two main subtypes, hilar (H), and peripheral (P) CC are described. The objective of the study was to compare, using MALDI imaging mass spectrometry (MALDI IMS), in situ proteomic profiles of H- and P-CC in order to assess whether these subtypes may express different markers and to describe their respective localizations. Twenty-seven CC (16 P-CC and 11 H-CC) were subjected to MALDI IMS. Proteomic data were submitted to a dedicated cross-classification comparative design, enabling comparison of the entire generated spectra. Immunohistochemistry was performed for validation. Comparative analysis yielded a list of 19 differential protein peaks for the two subtypes, 14 of which were overexpressed in H-CC and five in P-CC. Among H-CC protein markers, most discriminant were human neutrophil peptides 1-3 that were expressed mainly by tumor cells and S100 proteins (A6 and A11) that were restricted to the stromal area. In P-CC, thymosin β4 was diffusely overexpressed. These results highlight the potential of MALDI IMS to discover new relevant biomarkers of CC and to characterize the heterogeneity of the two different subtypes.

摘要

胆管癌(CC)是肝脏第二常见的原发性恶性肿瘤。尽管所有CC均起源于胆管上皮细胞,但可分为两种主要亚型,即肝门部(H)和周围型(P)CC。本研究的目的是使用基质辅助激光解吸电离成像质谱(MALDI IMS)比较H-CC和P-CC的原位蛋白质组图谱,以评估这些亚型是否可能表达不同的标志物并描述其各自的定位。对27例CC(16例P-CC和11例H-CC)进行了MALDI IMS检测。蛋白质组数据采用专门的交叉分类比较设计,以便对整个生成的光谱进行比较。采用免疫组织化学进行验证。比较分析得出了两种亚型的19个差异蛋白峰列表,其中14个在H-CC中过表达,5个在P-CC中过表达。在H-CC蛋白标志物中,最具鉴别力的是主要由肿瘤细胞表达的人中性粒细胞肽1-3和局限于基质区域的S100蛋白(A6和A11)。在P-CC中,胸腺素β4广泛过表达。这些结果突出了MALDI IMS在发现CC新的相关生物标志物以及表征两种不同亚型异质性方面的潜力。

相似文献

1
Tumoral heterogeneity of hepatic cholangiocarcinomas revealed by MALDI imaging mass spectrometry.基质辅助激光解吸电离成像质谱揭示肝内胆管癌的肿瘤异质性
Proteomics. 2014 Apr;14(7-8):965-72. doi: 10.1002/pmic.201300463.
2
[Pathology of cholangiocarcinoma].[胆管癌的病理学]
Ann Pathol. 2010 Dec;30(6):455-63. doi: 10.1016/j.annpat.2010.10.004. Epub 2010 Nov 27.
3
Proteomic profiling of cholangiocarcinoma: diagnostic potential of SELDI-TOF MS in malignant bile duct stricture.胆管癌的蛋白质组学分析:表面增强激光解吸电离飞行时间质谱在恶性胆管狭窄中的诊断潜力
Hepatology. 2006 Sep;44(3):658-66. doi: 10.1002/hep.21294.
4
Lipid profiles for intrahepatic cholangiocarcinoma identified using matrix-assisted laser desorption/ionization mass spectrometry.利用基质辅助激光解吸电离质谱鉴定肝内胆管癌的脂质谱。
Clin Chim Acta. 2011 Oct 9;412(21-22):1978-82. doi: 10.1016/j.cca.2011.07.008. Epub 2011 Jul 18.
5
In situ proteomic analysis by MALDI imaging identifies ubiquitin and thymosin-β4 as markers of malignant intraductal pancreatic mucinous neoplasms.通过基质辅助激光解吸电离成像进行的原位蛋白质组分析确定泛素和胸腺素-β4为胰腺导管内黏液性恶性肿瘤的标志物。
Pancreatology. 2014 Mar-Apr;14(2):117-24. doi: 10.1016/j.pan.2013.12.001. Epub 2013 Dec 17.
6
A prospective proteomic-based study for identifying potential biomarkers for the diagnosis of cholangiocarcinoma.一项基于蛋白质组学的前瞻性研究,旨在鉴定胆管癌诊断的潜在生物标志物。
J Gastrointest Surg. 2013 Sep;17(9):1584-91. doi: 10.1007/s11605-013-2182-9. Epub 2013 Jul 19.
7
Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.使用18O标记的差异膜蛋白质组学来鉴定胆管癌的生物标志物。
J Proteome Res. 2008 Nov;7(11):4670-7. doi: 10.1021/pr800215n. Epub 2008 Oct 8.
8
Global alterations of DNA methylation in cholangiocarcinoma target the Wnt signaling pathway.胆管癌中 DNA 甲基化的全局改变靶向 Wnt 信号通路。
Hepatology. 2014 Feb;59(2):544-54. doi: 10.1002/hep.26721. Epub 2013 Dec 24.
9
CD10+ fibroblasts are more involved in the progression of hilar/extrahepatic cholangiocarcinoma than of peripheral intrahepatic cholangiocarcinoma.CD10+ 纤维母细胞在肝门部/肝外胆管癌的进展中比在周围型肝内胆管癌中更为活跃。
Histopathology. 2009 Oct;55(4):423-31. doi: 10.1111/j.1365-2559.2009.03398.x.
10
Intrahepatic cholangiocarcinoma arising in chronic advanced liver disease and the cholangiocarcinomatous component of hepatocellular cholangiocarcinoma share common phenotypes and cholangiocarcinogenesis.在慢性进展性肝病中发生的肝内胆管细胞癌和肝细胞胆管癌的胆管癌成分具有共同的表型和胆管癌发生。
Histopathology. 2011 Dec;59(6):1090-9. doi: 10.1111/j.1365-2559.2011.04058.x.

引用本文的文献

1
MALDI Imaging, a Powerful Multiplex Approach to Decipher Intratumoral Heterogeneity: Combined Hepato-Cholangiocarcinomas as Proof of Concept.基质辅助激光解吸电离成像:一种用于解读肿瘤内异质性的强大多重分析方法——以肝内胆管混合癌为例的概念验证
Cancers (Basel). 2023 Apr 4;15(7):2143. doi: 10.3390/cancers15072143.
2
In situ Detecting Lipids as Potential Biomarkers for the Diagnosis and Prognosis of Intrahepatic Cholangiocarcinoma.原位检测脂质作为肝内胆管癌诊断和预后的潜在生物标志物。
Cancer Manag Res. 2022 Sep 26;14:2903-2912. doi: 10.2147/CMAR.S357000. eCollection 2022.
3
MALDI Mass Spectrometry Imaging for the Distinction of Adenocarcinomas of the Pancreas and Biliary Tree.
基质辅助激光解吸电离质谱成像在胰腺和胆道腺癌鉴别诊断中的应用。
Molecules. 2022 May 27;27(11):3464. doi: 10.3390/molecules27113464.
4
The Impact of Histological Annotations for Accurate Tissue Classification Using Mass Spectrometry Imaging.组织学注释对使用质谱成像进行准确组织分类的影响
Metabolites. 2021 Oct 30;11(11):752. doi: 10.3390/metabo11110752.
5
DEN-Induced Rat Model Reproduces Key Features of Human Hepatocellular Carcinoma.二乙基亚硝胺诱导的大鼠模型再现了人类肝细胞癌的关键特征。
Cancers (Basel). 2021 Oct 4;13(19):4981. doi: 10.3390/cancers13194981.
6
Evolution of the liver biopsy and its future.肝活检的发展历程及其未来。
Transl Gastroenterol Hepatol. 2021 Apr 5;6:20. doi: 10.21037/tgh.2020.04.01. eCollection 2021.
7
Mass spectrometry-based analysis of formalin-fixed, paraffin-embedded distal cholangiocarcinoma identifies stromal thrombospondin-2 as a potential prognostic marker.基于质谱的福尔马林固定、石蜡包埋的远端胆管癌分析鉴定出基质血栓调节蛋白-2 作为一种潜在的预后标志物。
J Transl Med. 2020 Sep 4;18(1):343. doi: 10.1186/s12967-020-02498-3.
8
Circulating Tumor Cells as a Tool for Assessing Tumor Heterogeneity.循环肿瘤细胞作为评估肿瘤异质性的工具。
Theranostics. 2019 Jun 19;9(16):4580-4594. doi: 10.7150/thno.34337. eCollection 2019.
9
Spatial Tissue Proteomics Quantifies Inter- and Intratumor Heterogeneity in Hepatocellular Carcinoma (HCC).空间组织蛋白质组学定量分析肝细胞癌 (HCC) 的肿瘤内和肿瘤间异质性。
Mol Cell Proteomics. 2018 Apr;17(4):810-825. doi: 10.1074/mcp.RA117.000189. Epub 2018 Jan 23.
10
Emerging proteomic technologies for elucidating context-dependent cellular signaling events: A big challenge of tiny proportions.用于阐明上下文相关细胞信号事件的新兴蛋白质组学技术:微小比例带来的巨大挑战。
Proteomics. 2015 May;15(9):1486-502. doi: 10.1002/pmic.201400448. Epub 2015 Feb 10.